Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Saphnelo
Marketing
Off-label drugs fall out of favor in lupus
New biologics in the form of GSK’s Benlysta and AstraZeneca’s Saphnelo have nearly doubled in use for systemic lupus erythematosus since 2021.
Ben Adams
Jun 16, 2023 10:16am
AZ rolls out first DTC campaign for lupus drug Saphnelo
May 11, 2022 4:47pm
AstraZeneca preps new lupus launch with patient-designed support
Aug 2, 2021 4:00pm
AstraZeneca's Saphnelo to challenge GSK's Benlysta in lupus
Aug 2, 2021 9:00am
